Table 1.
Baseline characteristics.
| Age (years) | |
| Median | 63 |
| Gender | |
| Male | 34 (65%) |
| Female | 18 (35%) |
| Race | |
| White | 38 (73%) |
| Black or African American | 3 (6%) |
| Asian | 4 (8%) |
| Native American/Pacific Islander | 0 (0%) |
| Other or Mixed Race | 7 (13%) |
| Ethnicity | |
| Hispanic | 6 (12%) |
| Non-Hispanic | 46 (88%) |
| Pathology | |
| Clear Cell RCC | 34 (81%) |
| Papillary RCC | 3 (6%) |
| Unclassified RCC | 4 (8%) |
| Collecting Duct RCC | 1 (2%) |
| XP Translocation | 2 (4%) |
| De Novo Metastatic Disease | 44 (85%) |
| Sarcomatoid Differentiation | 5 (10%) |
| Rhabdoid Differentiation | 5 (10%) |
| Baseline metastases | |
| Liver | 12 (23%) |
| Bone | 13 (25%) |
| Lymph node | 20 (38%) |
| Lung | 30 (58%) |
| IMDC risk | |
| Favorable | 3 (6%) |
| Intermediate | 31 (60%) |
| Poor | 13 (25%) |
| Unknown | 5 (10%) |